1. Home
  2. TRSG vs INTS Comparison

TRSG vs INTS Comparison

Compare TRSG & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRSG
  • INTS
  • Stock Information
  • Founded
  • TRSG 1996
  • INTS 2012
  • Country
  • TRSG Singapore
  • INTS United States
  • Employees
  • TRSG N/A
  • INTS N/A
  • Industry
  • TRSG
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRSG
  • INTS Health Care
  • Exchange
  • TRSG NYSE
  • INTS Nasdaq
  • Market Cap
  • TRSG 33.4M
  • INTS 33.4M
  • IPO Year
  • TRSG 2024
  • INTS 2023
  • Fundamental
  • Price
  • TRSG $1.91
  • INTS $2.23
  • Analyst Decision
  • TRSG
  • INTS Strong Buy
  • Analyst Count
  • TRSG 0
  • INTS 3
  • Target Price
  • TRSG N/A
  • INTS $8.50
  • AVG Volume (30 Days)
  • TRSG 2.9K
  • INTS 26.6K
  • Earning Date
  • TRSG 12-31-2024
  • INTS 03-13-2025
  • Dividend Yield
  • TRSG N/A
  • INTS N/A
  • EPS Growth
  • TRSG N/A
  • INTS N/A
  • EPS
  • TRSG N/A
  • INTS N/A
  • Revenue
  • TRSG $14,441,864.00
  • INTS N/A
  • Revenue This Year
  • TRSG N/A
  • INTS N/A
  • Revenue Next Year
  • TRSG N/A
  • INTS N/A
  • P/E Ratio
  • TRSG N/A
  • INTS N/A
  • Revenue Growth
  • TRSG 9.34
  • INTS N/A
  • 52 Week Low
  • TRSG $1.91
  • INTS $1.50
  • 52 Week High
  • TRSG $11.78
  • INTS $5.94
  • Technical
  • Relative Strength Index (RSI)
  • TRSG N/A
  • INTS 49.26
  • Support Level
  • TRSG N/A
  • INTS $1.84
  • Resistance Level
  • TRSG N/A
  • INTS $2.27
  • Average True Range (ATR)
  • TRSG 0.00
  • INTS 0.28
  • MACD
  • TRSG 0.00
  • INTS -0.01
  • Stochastic Oscillator
  • TRSG 0.00
  • INTS 56.36

About TRSG TUNGRAY TECHNOLOGIES INC

Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

Share on Social Networks: